According to a study involving six laboratories, multiplex immunofluorescent (mIF) imaging approaches support PD-1/PD-L1 proximity assessments across multiple sites and contribute to the accurate quantification of %PD-L1 expression in NSCLC tissue sections (85). The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.